Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate vs alendronate on bone geometry and strength in postmenopausal osteoporosis
2007-001509-11Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of strontium ranelate in osteoporosis and postmenopausal osteoporosis (2 arms), sponsored by Servier. Primary endpoint: Bone geometry and bone strength by pQCT. Started Sep 2007; status: completed.
02
Drugs
strontium ranelate
03
Conditions
osteoporosispostmenopausal osteoporosis
Beyond the preview
Go deeper on 2007-001509-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001509-11.